stars 1 stars 2 stars 3

ProQomics is pioneering high-throughput proteoform quantitation through a cutting-edge mass spectrometry platform. Our technology is designed to provide accurate, large-scale quantification of proteoforms and post-translationally modified proteins, empowering researchers and pharmaceutical companies to gain deeper insights into the molecular mechanisms of diseases. By combining multiplexed immuno arrays with high-resolution mass spectrometry, ProQomics enables faster, more detailed protein profiling—critical for drug discovery and biomarker development. Our products include innovative reagents, internal standards, and front-end instruments that streamline proteomics workflows, transforming how proteoforms are analyzed in research and industry.

ProQomics Questions

Tamil Anthonymuthu is the Founder and CEO of ProQomics.

3 people are employed at ProQomics.

Top ProQomics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users